Cargando…
Quality-Adjusted Life Years and Disability-Adjusted Life Years Are Better With Concurrent Chemoradiation Therapy Than Induction Chemotherapy Followed by Chemoradiation Therapy in Nasopharyngeal Carcinoma
Introduction As traditional measures such as overall survival (OS) or disease-free survival (DFS) alone do not give a holistic view of the outcomes of a treatment paradigm, we determine to add the evidence of quality-adjusted life year (QALY) and disability-adjusted life year (DALY) to the outcomes...
Autores principales: | Nittala, Mary R, Kanakamedala, Madhava R, Mundra, Eswar, Woods, William C, Smith, Maria L, Hamilton, Robert D, Jefferson, Gina D, Jackson, Lana, Packianathan, Satya, Vijayakumar, Srinivasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921606/ https://www.ncbi.nlm.nih.gov/pubmed/33665048 http://dx.doi.org/10.7759/cureus.13022 |
Ejemplares similares
-
Factors Affecting Outcomes in Patients With Stage III & IV Squamous Cell Carcinoma of Oropharynx: The Importance of p16 Status, BMI, and Race
por: Nittala, Mary R, et al.
Publicado: (2021) -
A 25-year Experience at an Academic Medical Center in the United States: Are There Racial Disparities in the Prognosis of Patients Diagnosed With Hypopharyngeal Carcinoma?
por: Vengaloor Thomas, Toms, et al.
Publicado: (2020) -
Concurrent Chemoradiation for Vaginal Cancer
por: Miyamoto, David T., et al.
Publicado: (2013) -
Achalasia Combined with Esophageal Cancer Treated by Concurrent Chemoradiation Therapy
por: Park, Jun Chul, et al.
Publicado: (2009) -
Organ Preservation for Advanced Laryngeal Cancer: Experience with Concurrent Chemoradiation Therapy
por: Arain, Asif Ali, et al.
Publicado: (2020)